![References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/26253975-3d5e-4262-b58c-11844cfe4f3a/gr3.jpg)
References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet
![Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma | SpringerLink Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-020-04021-6/MediaObjects/277_2020_4021_Fig1_HTML.png)
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma | SpringerLink
![Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b1cec494-ea17-4a37-b492-ecc067b7f18c/bjh15805-fig-0001-m.jpg)
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library
![How I manage patients with follicular lymphoma - Casulo - 2019 - British Journal of Haematology - Wiley Online Library How I manage patients with follicular lymphoma - Casulo - 2019 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9074358b-bc40-44c8-81e3-051706bcfedc/bjh16011-fig-0001-m.jpg)
How I manage patients with follicular lymphoma - Casulo - 2019 - British Journal of Haematology - Wiley Online Library
![The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival - Bishton - The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival - Bishton -](https://onlinelibrary.wiley.com/cms/asset/5e721d81-fe43-40b7-b097-50ebf163eff7/bjh16555-fig-0002-m.jpg)
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival - Bishton -
![Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management. - Abstract - Europe PMC Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3755934/bin/onc00813-1379-t04.jpg)
Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management. - Abstract - Europe PMC
![Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management. - Abstract - Europe PMC Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3755934/bin/onc00813-1379-t02.jpg)
Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management. - Abstract - Europe PMC
![LymphoCare, Massage & Skin Lotion for Healthy Lymphatic Circulation, Gallon- Buy Online in Brunei at brunei.desertcart.com. ProductId : 68412775. LymphoCare, Massage & Skin Lotion for Healthy Lymphatic Circulation, Gallon- Buy Online in Brunei at brunei.desertcart.com. ProductId : 68412775.](https://m.media-amazon.com/images/I/41HpX07vJIL.jpg)
LymphoCare, Massage & Skin Lotion for Healthy Lymphatic Circulation, Gallon- Buy Online in Brunei at brunei.desertcart.com. ProductId : 68412775.
![References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/056dbb82-d128-4813-a9b8-1ce6af9d1814/gr2.jpg)
References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet
![Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/128f7c89-5c8e-453e-ac65-9f32201e910d/bjh15805-fig-0002-m.jpg)
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library
![Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma | SpringerLink Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-020-04021-6/MediaObjects/277_2020_4021_Fig2_HTML.png)
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma | SpringerLink
![References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ad8af3af-d9cf-4a54-923c-82ee4edf50dd/gr1_lrg.gif)
References in Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial - The Lancet
![Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/69b905a3-d526-4bc6-8ffc-fd848b49233c/bjh.2019.185.issue-3.cover.jpg)
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population - Magnano - 2019 - British Journal of Haematology - Wiley Online Library
![High ten‐year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R‐FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study - Nastoupil - 2017 - British Journal of Haematology - High ten‐year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R‐FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study - Nastoupil - 2017 - British Journal of Haematology -](https://onlinelibrary.wiley.com/cms/asset/54f541ba-357c-49a2-afcb-e875eebd9510/bjh.2017.177.issue-2.cover.jpg)